Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1410-1418

  Seki, Masafumi ^a,b   Kohno, Shigeru ^a   Newstead, Michael W ^b   Zeng, Xianying ^b   Bhan, Urvashi ^b   Lukacs, Nicholas W ^c   Kunkel, Steven L ^c   Standiford, Theodore J ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; LEUKOCYTE ELASTASE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; TOLL LIKE RECEPTOR; ANTIBODY; AUTACOID; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EDEMA; ENZYME RELEASE; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MORTALITY; MOUSE; MUTANT; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ACUTE LUNG INJURY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DISEASE MODEL; DOG; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; METABOLISM; MOUSE MUTANT; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIRUS PNEUMONIA;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES; CELL LINE; DISEASE MODELS, ANIMAL; DOGS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RECEPTORS, INTERLEUKIN-8B;

EID: 77949313888     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901709     Document Type: Article

References (50)

1. Mandell, L. A., R. G. Wunderink, A. Anzueto, J. G. Bartlett, G. D. Campbell, N. C. Dean, S. F. Dowell, T. M. File, Jr., D. M. Musher, M. S. Niederman, et al; Infectious Diseases Society of America; American Thoracic Society. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl 2): S27-S72.
2. Glezen, W. P., S. B. Greenberg, R. L. Atmar, P. A. Piedra, and R. B. Couch. 2000. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283: 499-505.
3. Murphy, B. R., and R. Webster. 1996. Fields Virology, 3rd Ed. Lippencott-Raven, Philadelphia, p. 1397-1445.
4. Woodhead, M., F. Blasi, S. Ewig, G. Huchon, M. Ieven, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. Verheij; European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. 2005. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 26: 1138-1180.
5. Zuckerman, A. J., J. Banatvala, J. R. Pattison, P. D. Griffiths, and B. D. Schoub. 2004. Principals and Practice of Clnical Virology, 5th Ed. John Wiley and Sons, West Sussex, England.
6. Seki, M., K. Hashiguchi, K. Kosai, H. Higashiyama, K. Yanagihara, S. Kurihara, K. Izumikawa, M. Miyazaki, Y. Hirakata, T. Tashiro, and S. Kohno. 2006. A patient with fulminant primary influenza pneumonia which developed into secondary bacterial pneumonia. Acta Med. Nagasaki. 51: 121-124.
7. Seki, M., K. Kosai, K. Yanagihara, Y. Higashiyama, S. Kurihara, K. Izumikawa, Y. Miyazaki, Y. Hirakata, T. Tashiro, and S. Kohno. 2007. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern. Med. 46: 953-958.
8. Seki, M., N. Suyama, K. Hashiguchi, A. Hara, K. Kosai, S. Kurihara, S. Nakamura, K. Yamamoto, Y. Imamura, K. Izumikawa, et al. 2008. A patient with fulminant influenza-related bacterial pneumonia due to Streptococcus pneumoniae followed by Mycobacterium tuberculosis infection. Intern. Med. 47: 2043-2047.
9. Seki, M., K. Yanagihara, Y. Higashiyama, Y. Fukuda, Y. Kaneko, H. Ohno, Y. Miyazaki, Y. Hirakata, K. Tomono, J. Kadota, et al. 2004. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur. Respir. J. 24: 143-149.
10. Seki, M., Y. Higashiyama, K. Tomono, K. Yanagihara, H. Ohno, Y. Kaneko, K. Izumikawa, Y. Miyazaki, Y. Hirakata, Y. Mizuta, et al. 2004. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin. Exp. Immunol. 137: 35-40.
11. Kosai, K., M. Seki, K. Yanagihara, S. Nakamura, S. Kurihara, Y. Imamura, K. Izumikawa, H. Kakeya, Y. Yamamoto, T. Tashiro, and S. Kohno. 2008. Two-dimensional gel electrophoresis analysis in simultaneous influenza pneumonia and bacterial infection in mice. Clin. Exp. Immunol. 152: 364-371.
12. Seki, M., K. Kosai, A. Hara, Y. Imamura, S. Nakamura, S. Kurihara, K. Izumikawa, H. Kakeya, Y. Yamamoto, K. Yanagihara, et al. 2009. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection. Jpn. J. Infect. Dis. 62: 6-10.
13. Kosai, K., M. Seki, K. Yanagihara, S. Nakamura, S. Kurihara, K. Izumikawa, H. Kakeya, Y. Yamamoto, T. Tashiro, and S. Kohno. 2008. Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines. J. Int. Med. Res. 36: 322-328.
14. Kosai, K., M. Seki, K. Yanagihara, S. Nakamura, S. Kurihara, K. Izumikawa, H. Kakeya, Y. Yamamoto, T. Tashiro, and S. Kohno. 2008. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand. J. Infect. Dis. 40: 338-342.
15. Rosati, O., and M. U. Martin. 2002. Identification and characterization of murine IRAK-M. Biochem. Biophys. Res. Commun. 293: 1472-1477.
16. Wesche, H., X. Gao, X. Li, C. J. Kirschning, G. R. Stark, and Z. Cao. 1999. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274: 19403-19410.
17. Kobayashi, K., L. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. (Pubitemid 34876547)
18. Deng, J. C., G. Cheng, M. W. Newstead, X. Zeng, K. Kobayashi, R. A. Flavell, and T. J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116: 2532-2542.
19. Tateda, K., J. C. Deng, T. A. Moore, M.W. Newstead, R. Paine, 3rd, N. Kobayashi, K. Yamaguchi, and T. J. Standiford. 2003. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 170: 4209-4216. (Pubitemid 36428187)
20. Mehrad, B., R. M. Strieter, T. A.Moore,W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163: 6086-6094.
21. Moore, T. A., M. W. Newstead, R. M. Strieter, B. Mehrad, B. L. Beaman, and T. J. Standiford. 2000. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J. Immunol. 164: 908-915.
22. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68: 4289-4296.
23. Le Goffic, R., V. Balloy, M. Lagranderie, L. Alexopoulou, N. Escriou, R. A. Flavell, M. Chignard, and M. Si-Tahar. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2: 526-535. (Pubitemid 43998849)
24. Le Goffic, R., J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar. 2007. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178: 3368-3372. (Pubitemid 46417600)
25. Si-Tahar, M., L. Touqui, and M. Chignard. 2009. Innate immunity and inflammation - two facets of the same anti-infectious reaction. Clin. Exp. Immunol. 156: 194-198.
26. Brincks, E. L., T. A. Kucaba, K. L. Legge, and T. S. Griffith. 2008. Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells. Hum. Immunol. 69: 634-646.
27. Rintahaka, J., D. Wiik, P. E. Kovanen, H. Alenius, and S. Matikainen. 2008. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J. Immunol. 180: 1749-1757.
28. Adams, J. M., C. J. Hauser, D. H. Livingston, R. F. Lavery, Z. Fekete, and E. A. Deitch. 2001. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J. Trauma 51: 452-456, discussion 456-457.
29. Gordon, J. R., F. Li, X. Zhang, W. Wang, X. Zhao, and A. Nayyar. 2005. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. J. Leukoc. Biol. 78: 1265-1272.
30. Wang, J. P., G. N. Bowen, C. Padden, A. Cerny, R. W. Finberg, P. E. Newburger, and E. A. Kurt-Jones. 2008. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112: 2028-2034.
31. Scheiblauer, H., M. Reinacher, M. Tashiro, and R. Rott. 1992. Interactions between bacteria and influenza Avirus in the development of influenza pneumonia. J. Infect. Dis. 166: 783-791.
32. Peltola, V. T., K. G. Murti, and J. A. McCullers. 2005. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis. 192: 249-257.
33. Kuiken, T., G. F. Rimmelzwaan, G. Van Amerongen, and A. D. Osterhaus. 2003. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet. Pathol. 40: 304-310. (Pubitemid 38393580)
34. Wareing, M. D., A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar. 2004. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc. Biol. 76: 886-895.
35. Wareing, M. D., A. L. Shea, C. A. Inglis, P. B. Dias, and S. R. Sarawar. 2007. CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20: 369-378.
36. de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12: 1203-1207.
37. Ichinohe, T., H. K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206: 79-87.
38. Kim, J. H., M. H. Suk, D. W. Yoon, S. H. Lee, G. Y. Hur, K. H. Jung, H. C. Jeong, S. Y. Lee, S. Y. Lee, I. B. Suh,et al. 2006. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 291:L580-587.
39. Wang, S. Z., and K. D. Forsyth. 2000. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 5: 1-10.
40. Wang, S. Z., H. Xu, A. Wraith, J. J. Bowden, J. H. Alpers, and K. D. Forsyth. 1998. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur. Respir. J. 12: 612-618.
41. Zhao, Y., M. Lu, L. T. Lau, J. Lu, Z. Gao, J. Liu, A. C. Yu, Q. Cao, J. Ye, M. A. McNutt, and J. Gu. 2008. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clin. Infect. Dis. 47: 1575-1578.
42. Matute-Bello, G., W. C. Liles, K. P. Steinberg, P. A. Kiener, S. Mongovin, E. Y. Chi, M. Jonas, and T. R. Martin. 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163: 2217-2225. (Pubitemid 29382230)
43. Matute-Bello, G., R. K. Winn, M. Jonas, E. Y. Chi, T. R. Martin, and W. C. Liles. 2001. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol. 158: 153-161.
44. Brincks, E. L., A. Katewa, T. A. Kucaba, T. S. Griffith, and K. L. Legge. 2008. CD8 T cells utilize TRAIL to control influenza virus infection. J. Immunol. 181: 4918-4925.
45. Koyama, S., K. Ishii, H. Kumar, T. Tanimoto, C. Coban, S. Uematsu, T. Kawai, and S. Akira. 2007. Differential role of TLR- and RLR-signaling in the immune responses to influenza Avirus infection and vaccination. J. Immunol. 179: 4711-4720.
46. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603.
47. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
48. Harada, K., K. Isse, Y. Sato, S. Ozaki, and Y. Nakanuma. 2006. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int. 26: 935-942. (Pubitemid 44323411)
49. Skerrett, S. J., H. D. Liggitt, A. M. Hajjar, R. K. Ernst, S. I. Miller, and C. B. Wilson. 2004. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L143-L152.
50. Wang, J., R. Oberley-Deegan, S. Wang, M. Nikrad, C. J. Funk, K. L. Hartshorn, and R. J. Mason. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-l 1) in response to influenza A infection. J. Immunol. 182: 1296-1304.